Bayer and Beijing Anzhen Hospital of Capital Medical University Successfully Sign Pharmaceutical Procurement Agreement at the Second China International Import Expo

Shanghai, November 7, 2019 /PRNewswire/ -- On November 7, the Beijing delegation for medical devices and pharmaceutical supplies signed major deals at the pharmaceutical exhibition hall of the Second China International Import Expo. At the signing ceremony organized by the Medical Administration Center of the Beijing Municipal Health Commission for the Beijing Pharmaceutical Procurement Delegation, Dr. Lin Yang, Director of the Pharmacy Department at Beijing Anzhen Hospital, Capital Medical University, visited the Bayer booth and engaged in cordial exchanges with Dr. Gao Yong, Vice President of Public & Government Affairs and Sustainability at Bayer Greater China, and Ms. Qian Kun, Director of Market Access Platform, Bayer Prescription Drugs Division.

Anzhen Hospital is a large comprehensive Grade 3A hospital with cardiovascular disease treatment as its key specialty. The two parties engaged in in-depth discussions on pharmacological treatment and drug innovation in the field of cardiovascular diseases, and exchanged views on Bayer’s products and their distribution at Anzhen Hospital.

Entrusted by the Medical Administration Center of the Beijing Municipal Health Commission, Beijing Anzhen Hospital actively participated in the pharmaceutical procurement contracts at this China International Import Expo. Adhering to the principle of fairness, both parties signed a letter of intent for drug procurement at the Bayer booth, with the planned completion of procurement scheduled for 2020.